Sigma Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Sigma Planning's ARKG Position: Q3 2026 in Review
Sigma Planning reduced its ARK Genomic Revolution ETF (ARKG) stake by 23% in Q3 2026, selling an estimated $129K and leaving 9,387 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #841.
Sigma Planning first reported a position in ARKG in Q2 2019 and has held it in 25 quarters since. The position peaked at $9.7M in Q4 2020. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Sigma Planning held 9,387 shares of ARK Genomic Revolution ETF worth $494K as of Q3 2026.
- Sigma Planning sold 2,862 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $129K.
- ARK Genomic Revolution ETF made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #841 holding.
- Sigma Planning first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 25 quarters since.
- Sigma Planning's ARK Genomic Revolution ETF position peaked at $9.7M in Q4 2020.
- 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.